| Factor . | n = 514 . |
|---|---|
| Age (years) | |
| Mean ± SD | 67 ± 10 |
| Range | 17–86 |
| Sex, n (%) | |
| Male | 278 (54) |
| Female | 236 (46) |
| BMI, n (%) | |
| <18.5 | 53 (10) |
| 18.5 ≤ BMI < 25 | 377 (73) |
| 25 ≤ BMI < 30 | 80 (16) |
| ≥30 | 4 (1) |
| Smoking status, n (%) | |
| Never | 239 (46) |
| Smoker | 275 (54) |
| %FEV1, n (%) | |
| <80% | 99 (19) |
| ≥80% | 415 (81) |
| %DLco, n (%) | |
| <80% | 177 (34) |
| ≥80% | 337 (66) |
| ppo%FEV1, n (%) | |
| <60% | 69 (13) |
| ≥60% | 445 (87) |
| ppo%DLco, n (%) | |
| <60% | 121 (24) |
| ≥60% | 393 (76) |
| Aortic valve disease, n (%) | 15 (3) |
| Mitral valve disease, n (%) | 12 (2) |
| Congestive heart failure, n (%) | 16 (3) |
| Coronary artery disease, n (%) | 40 (8) |
| Hypertension, n (%) | 164 (32) |
| Diabetes mellitus, n (%) | 80 (16) |
| Cerebrovascular disease, n (%) | 32 (6) |
| Atrial fibrillation, n (%) | 22 (4) |
| Atherosclerotic disease, n (%) | 50 (10) |
| Chronic kidney disease, n (%) | 46 (9) |
| COPD, n (%) | 103 (20) |
| Interstitial lung disease, n (%) | 25 (5) |
| Liver disease, n (%) | 27 (5) |
| History of other cancers, n (%) | 151 (29) |
| Factor . | n = 514 . |
|---|---|
| Age (years) | |
| Mean ± SD | 67 ± 10 |
| Range | 17–86 |
| Sex, n (%) | |
| Male | 278 (54) |
| Female | 236 (46) |
| BMI, n (%) | |
| <18.5 | 53 (10) |
| 18.5 ≤ BMI < 25 | 377 (73) |
| 25 ≤ BMI < 30 | 80 (16) |
| ≥30 | 4 (1) |
| Smoking status, n (%) | |
| Never | 239 (46) |
| Smoker | 275 (54) |
| %FEV1, n (%) | |
| <80% | 99 (19) |
| ≥80% | 415 (81) |
| %DLco, n (%) | |
| <80% | 177 (34) |
| ≥80% | 337 (66) |
| ppo%FEV1, n (%) | |
| <60% | 69 (13) |
| ≥60% | 445 (87) |
| ppo%DLco, n (%) | |
| <60% | 121 (24) |
| ≥60% | 393 (76) |
| Aortic valve disease, n (%) | 15 (3) |
| Mitral valve disease, n (%) | 12 (2) |
| Congestive heart failure, n (%) | 16 (3) |
| Coronary artery disease, n (%) | 40 (8) |
| Hypertension, n (%) | 164 (32) |
| Diabetes mellitus, n (%) | 80 (16) |
| Cerebrovascular disease, n (%) | 32 (6) |
| Atrial fibrillation, n (%) | 22 (4) |
| Atherosclerotic disease, n (%) | 50 (10) |
| Chronic kidney disease, n (%) | 46 (9) |
| COPD, n (%) | 103 (20) |
| Interstitial lung disease, n (%) | 25 (5) |
| Liver disease, n (%) | 27 (5) |
| History of other cancers, n (%) | 151 (29) |
BMI: body mass index; COPD: chronic obstructive pulmonary disease; DLco: carbon monoxide lung diffusion capacity; %FEV1: % forced expiratory volume in 1 s; ppo: predicted postoperative; SD: standard deviation.
| Factor . | n = 514 . |
|---|---|
| Age (years) | |
| Mean ± SD | 67 ± 10 |
| Range | 17–86 |
| Sex, n (%) | |
| Male | 278 (54) |
| Female | 236 (46) |
| BMI, n (%) | |
| <18.5 | 53 (10) |
| 18.5 ≤ BMI < 25 | 377 (73) |
| 25 ≤ BMI < 30 | 80 (16) |
| ≥30 | 4 (1) |
| Smoking status, n (%) | |
| Never | 239 (46) |
| Smoker | 275 (54) |
| %FEV1, n (%) | |
| <80% | 99 (19) |
| ≥80% | 415 (81) |
| %DLco, n (%) | |
| <80% | 177 (34) |
| ≥80% | 337 (66) |
| ppo%FEV1, n (%) | |
| <60% | 69 (13) |
| ≥60% | 445 (87) |
| ppo%DLco, n (%) | |
| <60% | 121 (24) |
| ≥60% | 393 (76) |
| Aortic valve disease, n (%) | 15 (3) |
| Mitral valve disease, n (%) | 12 (2) |
| Congestive heart failure, n (%) | 16 (3) |
| Coronary artery disease, n (%) | 40 (8) |
| Hypertension, n (%) | 164 (32) |
| Diabetes mellitus, n (%) | 80 (16) |
| Cerebrovascular disease, n (%) | 32 (6) |
| Atrial fibrillation, n (%) | 22 (4) |
| Atherosclerotic disease, n (%) | 50 (10) |
| Chronic kidney disease, n (%) | 46 (9) |
| COPD, n (%) | 103 (20) |
| Interstitial lung disease, n (%) | 25 (5) |
| Liver disease, n (%) | 27 (5) |
| History of other cancers, n (%) | 151 (29) |
| Factor . | n = 514 . |
|---|---|
| Age (years) | |
| Mean ± SD | 67 ± 10 |
| Range | 17–86 |
| Sex, n (%) | |
| Male | 278 (54) |
| Female | 236 (46) |
| BMI, n (%) | |
| <18.5 | 53 (10) |
| 18.5 ≤ BMI < 25 | 377 (73) |
| 25 ≤ BMI < 30 | 80 (16) |
| ≥30 | 4 (1) |
| Smoking status, n (%) | |
| Never | 239 (46) |
| Smoker | 275 (54) |
| %FEV1, n (%) | |
| <80% | 99 (19) |
| ≥80% | 415 (81) |
| %DLco, n (%) | |
| <80% | 177 (34) |
| ≥80% | 337 (66) |
| ppo%FEV1, n (%) | |
| <60% | 69 (13) |
| ≥60% | 445 (87) |
| ppo%DLco, n (%) | |
| <60% | 121 (24) |
| ≥60% | 393 (76) |
| Aortic valve disease, n (%) | 15 (3) |
| Mitral valve disease, n (%) | 12 (2) |
| Congestive heart failure, n (%) | 16 (3) |
| Coronary artery disease, n (%) | 40 (8) |
| Hypertension, n (%) | 164 (32) |
| Diabetes mellitus, n (%) | 80 (16) |
| Cerebrovascular disease, n (%) | 32 (6) |
| Atrial fibrillation, n (%) | 22 (4) |
| Atherosclerotic disease, n (%) | 50 (10) |
| Chronic kidney disease, n (%) | 46 (9) |
| COPD, n (%) | 103 (20) |
| Interstitial lung disease, n (%) | 25 (5) |
| Liver disease, n (%) | 27 (5) |
| History of other cancers, n (%) | 151 (29) |
BMI: body mass index; COPD: chronic obstructive pulmonary disease; DLco: carbon monoxide lung diffusion capacity; %FEV1: % forced expiratory volume in 1 s; ppo: predicted postoperative; SD: standard deviation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
